Regeneron has pledged to adhere to 23andMe’s stringent privacy policies concerning customer data, presenting their intentions to a court-appointed overseer.
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
The bankruptcy filing in March had raised concerns among lawmakers regarding the privacy of genetic information belonging to over 15 million customers. In response, 23andMe consented to oversight of its data management practices.
Despite the data breach in 2023 and declining demand for their testing kits, 23andMe’s integration into Regeneron aims to drive innovation. Excluding Lemonaid Health, all 23andMe units will merge with Regeneron to continue as an autonomous entity.